Positron emission tomography (PET) imaging with 68gallium-labeled prostate-specific membrane antigen ligands (68Ga-PSMA) may be promising for the detection of recurrent tumors11; however, 68Ga-PSMA PET is utilized only in some countries and may be difficult to detect minimal tumor burden in early SRT. This evidence concerns the gene FOLH1 and neoplasm.